Lynk Pharmaceuticals Competitors and Similar CompaniesClear all

Pfizer's competitors and similar companies include BridgeBio.
Pfizer
Pfizer
Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
BridgeBio
BridgeBio
BridgeBio is a company focused on discovering and developing drugs for patients with grievous genetic diseases.
Founding Date
Founding Date
1849
Founding Date
2014
Type
Type
Public
Type
Public
Tags
Locations
Locations
New York, US HQ
Buenos Aires, AR
Villa Adelina, AR
Footscray, AU
Mulgrave, AU
Sydney, AU
Wien, AT
see more
Locations
Palo Alto, US HQ
Employees
Employees
81,0008% decrease
Employees
24863% increase
Valuation ($)
Valuation ($)
163.9 b
Valuation ($)
4.6 b

Financial

Revenue (est.)
Revenue (est.)
$62.6b (FY, 2025)
Revenue (est.)
$502.1m (FY, 2025)
Cost of goods
Cost of goods
$16.1b (FY, 2025)
Cost of goods
$21m (FY, 2025)
Gross profit
Gross profit
$46.5b (FY, 2025)
Gross profit
$481.1m (FY, 2025)
Net income
Net income
$7.8b (FY, 2025)
Net income
($732.9m) (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

BridgeBio
HQ
Palo Alto, US
Employees
248

BridgeBio is a company focused on discovering and developing drugs for patients with grievous genetic diseases.

View company